In two patients with chronic hepatitis C who had failed prior pegylated interferon and ribavirin, triple therapy with thymosin alpha‑1, pegylated interferon and ribavirin was followed by sustained virological responses.
In plain wordsTwo people with hepatitis C who had failed earlier treatment reached a sustained virus response on a three-drug regimen that included thymosin alpha‑1.
- Peptide
- Thymosin alpha-1
- Outcome
- IncreaseSustained virological response after triple therapy
- Study
n = 2
- Outcome group
- Antiviral activity · Infection
Source sentences
They received triple combination therapies of thymosin alpha 1, pegylated interferon and ribavirin and achieved sustained virological responses.
1 context sentence(design, population, supporting numbers)
Herein, we describe two cases of retreatment patients with chronic hepatitis C who have failed prior pegylated interferon and ribavirin therapy.
In this study, Thymosin alpha-1 was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin alpha-1.